Activated CD21low CD38- B Cells and Their Antibodies: Markers of Chronic Immune Activation
Activated CD21low CD38- B cells are a distinct subset of B lymphocytes linked to chronic immune activation and immune dysregulation. These cells are characterized by:
- Low CD21 expression: A complement receptor involved in B cell activation and antigen binding.
- Absence of CD38: A marker typically associated with B cell activation and differentiation.
- Elevated activation markers: Such as CD80 and CD86.
- Increased inhibitory receptors: Including PD-1 and FCRL4.
Antibodies Produced by CD21low CD38- B Cells
- Isotypes: Primarily class-switched antibodies (e.g., IgG, IgA).
- Specificity: Includes autoreactive antibodies and those targeting persistent antigens.
- Affinity: May exhibit reduced affinity maturation due to impaired participation in germinal centers.
Functional Significance
These cells and their antibodies are associated with:
- Chronic activation: Linked to persistent antigen exposure and inflammation.
- Exhaustion-like phenotype: Similar to exhausted T cells, they show reduced responsiveness to BCR and CD40 signaling.
- Cytokine production: Secrete pro-inflammatory cytokines, including IL-6 and TNF-α.
Clinical Associations
- Autoimmune diseases:
- Systemic lupus erythematosus (SLE).
- Rheumatoid arthritis (RA).
- Sjögren's syndrome.
- Chronic infections:
- HIV, hepatitis C virus (HCV), malaria.
- Primary immunodeficiencies:
- Common Variable Immunodeficiency (CVID).
- Age-related immune dysfunction.
Recent Research Developments
- Single-cell analysis: Highlights heterogeneity within the CD21low CD38- population.
- Epigenetic studies: Explore regulation of this subset's development and function.
- Therapeutic targeting: Investigating approaches to modulate or deplete these cells in autoimmune conditions.
Diagnostic and Therapeutic Implications
Monitoring activated CD21low CD38- B cells and their antibodies offers valuable insights into:
- Chronic immune activation and disease progression in autoimmune disorders and infections.
- Efficacy of immunomodulatory therapies.
- Potential biomarkers for immune exhaustion or dysregulation.
Conclusion
Activated CD21low CD38- B cells and their antibodies are critical markers of chronic immune activation and immune dysregulation, playing key roles in autoimmune diseases, chronic infections, and primary immunodeficiencies. Their presence and function provide essential diagnostic and therapeutic insights, though interpretation must account for the broader immune context and clinical presentation.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.